Inspire Investing’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$675K Buy
14,285
+5,532
+63% +$284K 0.03% 835
2026
Q1
$519K Buy
8,753
+1,159
+15% +$75.2K 0.03% 552
2025
Q4
$468K Buy
7,594
+329
+5% +$20.1K 0.04% 470
2025
Q3
$453K Buy
7,265
+2,375
+49% +$165K 0.04% 602
2025
Q2
$390K Buy
4,890
+888
+22% +$74.3K 0.04% 495
2025
Q1
$344K Sell
4,002
-1,119
-22% -$91.8K 0.04% 510
2024
Q4
$400K Sell
5,121
-581
-10% -$45.1K 0.04% 641
2024
Q3
$411K Buy
5,702
+599
+12% +$42.4K 0.04% 648
2024
Q2
$351K Buy
5,103
+42
+0.8% +$2.85K 0.04% 597
2024
Q1
$367K Sell
5,061
-1,251
-20% -$83.6K 0.04% 416
2023
Q4
$386K Buy
6,312
+960
+18% +$57K 0.04% 447
2023
Q3
$306K Buy
5,352
+90
+2% +$5.44K 0.04% 656
2023
Q2
$313K Buy
5,262
+902
+21% +$54K 0.04% 710
2023
Q1
$273K Buy
4,360
+630
+17% +$39.3K 0.03% 599
2022
Q4
$233K Sell
3,730
-635
-15% -$36.4K 0.03% 734
2022
Q3
$218K Buy
4,365
+457
+12% +$25.3K 0.03% 336
2022
Q2
$230K Sell
3,908
-536
-12% -$29.5K 0.03% 336
2022
Q1
$235K Buy
4,444
+397
+10% +$22.9K 0.03% 619
2021
Q4
$245K Sell
4,047
-111
-3% -$6.59K 0.03% 732
2021
Q3
$233K Buy
+4,158
New +$228K 0.03% 535
2020
Q2
Sell
-5,938
Closed -$218K 653
2020
Q1
$218K Buy
+5,938
New +$231K 0.09% 361
2018
Q1
Sell
-1,249
Closed -$55K 548
2017
Q4
$55K Buy
+1,249
New +$56.9K 0.05% 632

Other funds holding PBH

Inspire Investing's PBH Position: Q2 2026 in Review

Inspire Investing increased its Prestige Consumer Healthcare (PBH) stake by 63% in Q2 2026, buying an estimated $284K and bringing the position to 14,285 shares worth $675K. The position accounts for 0.03% of the portfolio, ranked #835.

Inspire Investing first reported a position in PBH in Q4 2017 and has held it in 22 quarters since. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Inspire Investing held 14,285 shares of Prestige Consumer Healthcare worth $675K as of Q2 2026.
  • Inspire Investing bought 5,532 Prestige Consumer Healthcare shares in Q2 2026, an estimated $284K.
  • Prestige Consumer Healthcare made up 0.03% of Inspire Investing's portfolio in Q2 2026, its #835 holding.
  • Inspire Investing first reported a position in Prestige Consumer Healthcare in Q4 2017 and has held it in 22 quarters since.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.